Eirion Therapeutics
PrivateLast Round
Series A
Mar 9, 2021
Total Funding Raised
$43M
Company Overview
Eirion Therapeutics operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Series A round in March 2021.
Eirion Therapeutics is a biopharmaceutical company that develops prescription products for aesthetic dermatology, including treatments for wrinkles, hyperhidrosis, hair loss, and hair greying.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eirion Therapeutics Comparables
Compare Eirion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 74% | |
| Amplifica Holdings Group, Inc. | 73% | |
| Merz | 72% |
For institutional investors. Book with your work email.
Eirion Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eirion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gore Range Capital | Series A |
| Kinled Holding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Will present at the Society for Investigative Dermatology 2025 annual meeting.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
Eirion Thera to present first-in-human ET-02 data for androgenetic alopecia at the Third BCN Hair Meeting in Sitges, Spain, from Sep 17th–19th '26.
For institutional investors. Book with your work email.
Eirion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eirion Therapeutics's valuation, stock price, and market status.
Is Eirion Therapeutics a public or private company?
Eirion Therapeutics is a private company.
What is the current stock price of Eirion Therapeutics?
Eirion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eirion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eirion Therapeutics worth (valuation)?
Valuation information for Eirion Therapeutics is not publicly available.
Can I buy Eirion Therapeutics stock?
Eirion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eirion Therapeutics's last funding round?
Eirion Therapeutics's most recent funding round was Series A on March 9, 2021.
Who are the main investors in Eirion Therapeutics?
Key investors in Eirion Therapeutics include Gore Range Capital, Kinled Holding.
Will Eirion Therapeutics IPO soon?
No public IPO plans have been announced for Eirion Therapeutics.
How can I track Eirion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Eirion Therapeutics's shares on secondary markets.